SHARIR DAFNA - 20 Jun 2025 Form 4 Insider Report for ORMAT TECHNOLOGIES, INC. (ORA)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
24 Jun 2025, 16:24:52 UTC
Prior SEC filing
21 May 2025
Next SEC filing
01 Oct 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Jessica Woelfel - as attorney-in-fact

Key filing fact

SHARIR DAFNA filed Form 4 for ORMAT TECHNOLOGIES, INC. (ORA) on 24 Jun 2025.

Key facts

  • This page summarizes SHARIR DAFNA's Form 4 filing for ORMAT TECHNOLOGIES, INC. (ORA).
  • 9 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 24 Jun 2025, 16:24.

Change

  • Previous filing in this sequence was filed on 21 May 2025.
  • Current net transaction value: -$137,001.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001181711 Primary reporting owner

SHARIR DAFNA

Relationship
Director
Address
C/O ORMAT TECHNOLOGIES, INC., 6884 SIERRA CENTER PARKWAY, RENO
Signature
/s/ Jessica Woelfel - as attorney-in-fact
Signature date
24 Jun 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ORA transaction

Common Stock

Options Exercise

Transaction value
$93,013
Shares
+1,210
Change %
+27%
Price
$76.87
Shares after
5,648
Date
20 Jun 2025
Ownership
Direct
Footnotes
F1
ORA transaction

Common Stock

Disposed to Issuer

Transaction value
$92,957
Shares
-1,089
Change %
-19%
Price
$85.36
Shares after
4,559
Date
20 Jun 2025
Ownership
Direct
Footnotes
F1
ORA transaction

Common Stock

Sale

Transaction value
$10,366
Shares
-121
Change %
-2.7%
Price
$85.67
Shares after
4,438
Date
20 Jun 2025
Ownership
Direct
Footnotes
F1
ORA transaction

Common Stock

Options Exercise

Transaction value
$88,815
Shares
+1,315
Change %
+30%
Price
$67.54
Shares after
5,753
Date
20 Jun 2025
Ownership
Direct
Footnotes
F2
ORA transaction

Common Stock

Disposed to Issuer

Transaction value
$88,782
Shares
-1,035
Change %
-18%
Price
$85.78
Shares after
4,718
Date
20 Jun 2025
Ownership
Direct
Footnotes
F2
ORA transaction

Common Stock

Sale

Transaction value
$24,027
Shares
-280
Change %
-5.9%
Price
$85.81
Shares after
4,438
Date
20 Jun 2025
Ownership
Direct
Footnotes
F2
ORA transaction

Common Stock

Sale

Transaction value
$102,696
Shares
-1,200
Change %
-27%
Price
$85.58
Shares after
3,238
Date
20 Jun 2025
Ownership
Direct
Footnotes
F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ORA transaction Derivative

Stock Appreciation Rights (SARS)

Options Exercise

Transaction value
$0
Shares
-1,210
Change %
-100%
Price
$0.000000
Shares after
0
Date
20 Jun 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,210
Exercise price
$76.87
ORA transaction Derivative

Stock Appreciation Rights (SARS)

Options Exercise

Transaction value
$0
Shares
-1,315
Change %
-100%
Price
$0.000000
Shares after
0
Date
20 Jun 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,315
Exercise price
$67.54
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Represents the exercise of Stock Appreciation Rights (SARS) expiring on November 06, 2025, for which the reporting person exercised all 1,210 shares, disposed of 1,089 shares to the issuer to cover the exercise price of the SARs, and sold the remaining 121 shares acquired upon exercise in the open market on June 20, 2025. Each SAR represents the right to receive shares of ORA common stock with a value equal to the amount by which the market value of the shares in respect of which the SAR is exercised exceeds the grant price set forth in the SAR, multiplied by the number of shares in respect of which the SAR is exercised.

Footnote F2

Represents the exercise of SARS expiring on November 04, 2026, for which the reporting person exercised all 1,315 shares, disposed of 1,035 shares to the issuer to cover the exercise price of the SARs, and sold the remaining 280 shares in the open market on June 20, 2025.

Footnote F3

Represents shares of common stock sold in the open market on June 20, 2025.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .